APA (7th ed.) Citation

Shinto, E., Oki, E., Shimokawa, M., Yamaguchi, S., Ishiguro, M., Hasegawa, S., . . . Hase, K. (2023). ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients. Annals of Surgical Oncology, 30(8), 5250-5251. https://doi.org/10.1245/s10434-023-13684-0

Chicago Style (17th ed.) Citation

Shinto, Eiji, et al. "ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients." Annals of Surgical Oncology 30, no. 8 (2023): 5250-5251. https://doi.org/10.1245/s10434-023-13684-0.

MLA (9th ed.) Citation

Shinto, Eiji, et al. "ASO Visual Abstract: Enhanced Clinical Utility of Molecular Budding Signature as a Recurrence Risk Determinant in Stage II and III Colon Cancer Patients." Annals of Surgical Oncology, vol. 30, no. 8, 2023, pp. 5250-5251, https://doi.org/10.1245/s10434-023-13684-0.